DAPT meets its MASTER webinar
Part 1 : The unknown HBR patient
29 novembre - 18h00 - 19h00
Part 1 : The unknown HBR patient
Program
| 18h00 | Introduction & Patient case |
| Managing different HBR scenarios |
|
| Q&A |
|
| Conclusion & take home message |
Educational Objectives:
- Mastering the latest data on HBR and DAPT duration
- Learn on the potential impact on clinical practice under the lights of MASTER DAPT
- Put it into practice with HBR patient case
MASTER DAPT study is sponsored by the European Cardiovascular Research Institute (ECRI, Rotterdam, The Netherlands) and supported with a restricted research grant by Terumo Europe.
Ultimaster™ Tansei™ and Ultimaster™ DES are not available for sales in all countries. Please contact your Terumo local sales representatives for more information.